SELLAS Life Sciences Group, Inc. - SLS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 09, 2026 | — | A | A | 50,000.0 | 0.0 | 0.0 | 72,900.0 | View | |
| Jan 09, 2026 | — | A | A | 50,000.0 | 0.0 | 0.0 | 82,900.0 | View | |
| Jan 09, 2026 | — | A | A | 50,000.0 | 0.0 | 0.0 | 73,082.0 | View | |
| Jan 09, 2026 | SVP, Chief Development Officer | A | A | 300,000.0 | 0.0 | 0.0 | 557,805.0 | View | |
| Jan 09, 2026 | CFO | A | A | 300,000.0 | 0.0 | 0.0 | 554,327.0 | View | |
| Jan 09, 2026 | — | A | A | 50,000.0 | 0.0 | 0.0 | 154,400.0 | View | |
| Jan 09, 2026 | — | A | A | 50,000.0 | 0.0 | 0.0 | 92,900.0 | View | |
| Dec 05, 2025 | SVP, Chief Development Officer | J | D | 63,800.0 | 1.5 | 95,700.0 | 257,805.0 | View | |
| Dec 05, 2025 | CFO | J | D | 58,592.0 | 1.5 | 87,888.0 | 254,327.0 | View | |
| Dec 05, 2025 | President and CEO | J | D | 187,066.0 | 1.5 | 280,599.0 | 686,966.0 | View | |
| Nov 21, 2025 | — | P | A | 63,400.0 | 1.59 | 100,806.0 | 104,400.0 | View |